Login to comment
[속보] NYT: 모더나, FDA에 자사 백신 긴급사용 승인 요청— Wan Ki Choi (@wkchoi) November 30, 2020
- 이는 빠르면 12월 21일까지 미국인들에게 접종 시작할 수 있을 것으로 예상
- 모더나, 11월 16일 공개한 3만명 대상 3상 시험 결과에 따르면 자가가 개발한 백신은 94.5% 효과 보이는 것으로 나타나https://t.co/yGc21W9BW7
Covid-19: Moderna submits vaccine for FDA regulatory approval. Moderna said the vaccine was 100 percent effective at preventing severe cases of the disease. @AlexanderSmith https://t.co/jdxoGbLB24 via @nbcnews— Susan Kroll (@suekroll) November 30, 2020
Really enjoying this trend of ??Mondays with ?? big ?? vaccine ?? news ??https://t.co/uXQhu7C6QU— Jane C. Timm (@janestreet) November 30, 2020
Moderna submits vaccine for approval, says trial shows 100% efficacy against 'severe' Covid: Recent vaccine developments have been met with optimism among scientists and stock markets, but experts also urge caution until more data is released. https://t.co/3N39McMxdp— Jeffrey Levin (@jilevin) November 30, 2020
Moderna statement:— Jim Roberts (@nycjim) November 30, 2020
*94.1 percent efficacy rate.
*Vaccine is 100 percent effective in preventing severe cases of #covid19.
*Trial results were the across all age, race and gender categories.
*Side effects: Fatigue, muscle/joint pain, headaches.https://t.co/RAZNqAbEYl
Break: Moderna will today submit its vaccine for regulatory approval, says Phase 3 trial showed 100% efficacy against "severe" Covid-19: 30 people out of the 30,000-strong study became severely ill and one died - but all of them were in the placebo group.https://t.co/j0ZsikBWqW— Alexander Smith (@AlexanderSmith) November 30, 2020
Covid-19: Moderna submits vaccine for FDA regulatory approval https://t.co/2HkeWkkCn5— Gabe Gutierrez (@gabegutierrez) November 30, 2020
Moderna submits vaccine for approval, says trial shows 100% efficacy against 'severe' #COVID cases.— Marvi Sirmed (@marvisirmed) November 30, 2020
Recent vaccine developments have been met with optimism among scientists and stock markets, but experts also urge caution until more data is released. https://t.co/CnstO0X27w
Science by press release!! No peer reviewed data. This has never happened before.https://t.co/v0NqW2CK1d— Dr. Urso (@richardursomd) November 30, 2020
Moderna's #COVID19 vaccine final results are in...and are impressive:— Isaac Bogoch (@BogochIsaac) November 30, 2020
-196 cases of covid: 185 in placbo & 11 in vaccine group.
-30 severe covid cases, ALL in placebo group.
Yes...science via press release & need to see data, but still very exciting. https://t.co/2JED75ZTlI
“The first injections may be given as early as Dec. 21 if the process goes smoothly and approval is granted.”https://t.co/mFehEjDpuz— CAP Action (@CAPAction) November 30, 2020
Moderna has filed for its Emergency Use Authorization! I have not read as much on this vaccine as I have on Pfizer/BioNTech's BNT162b1, because there was no chance of me being injected with it experimentally. But it is also mRNA.— ?Shepherd? (@NeolithicSheep) November 30, 2020
Big news to start the week – Moderna announced they plan to ask @US_FDA for emergency clearance on their COVID vaccine, which is more than 94% effective, later today. This means that some Americans could receive the first dose of the vaccine in a few weeks https://t.co/cU21frEA53— Senator Roy Blunt (@RoyBlunt) November 30, 2020
Uh oh ... we should expect tweets from @realDonaldTrump, @IvankaTrump and the rest of those wastrels claiming credit for this vaccine too ?https://t.co/GR3lFMm3jj— Piyush Mittal (@piyushmittal) November 30, 2020
Moderna Covid vaccine is 94.1% effective, plans to apply for emergency OK Monday https://t.co/38SaRS6qGi— Dr. Preneur, MD (@erikaash13) November 30, 2020
BREAKING: Moderna said it will request emergency clearance from the FDA for its coronavirus vaccine after data shows the vaccine is 94.1% effective in preventing Covid-19. https://t.co/kOrZOPTUGa— Berkeley Lovelace (@BerkeleyJr) November 30, 2020
GREAT news to start the week ⬇️— Karoline Leavitt (@KLeavitt45) November 30, 2020
Moderna will request emergency clearance from @US_FDA for it's COVID-19 Vaccine!
Thank you President @realDonaldTrump, @Mike_Pence @SecAzar, and everyone working hard to secure a safe vaccine through #OperationWarpSpeed!https://t.co/eP1EXY6n9d
Moderna says new data shows Covid vaccine is more than 94% effective, plans to ask FDA for emergency clearance later today https://t.co/cwMAZ0o9z3— Travis Akers (@travisakers) November 30, 2020
#COVID19 Update | @moderna_tx says new data shows Covid vaccine is more than 94% effective, plans to ask FDA for emergency clearance later Mondayhttps://t.co/iS4nSjqFWQ— CNBC-TV18 (@CNBCTV18Live) November 30, 2020
Login to comment
Moderna Is Applying for Emergency F.D.A. Approval for Its Coronavirus Vaccine. If granted, vaccination could start as esrly as 21st of December - The New York Times #COVIDー19 @nytimes https://t.co/Vi5K7JsQo2— Yale Tung Chen (@yaletung) December 1, 2020
Modernaのワクチン候補は15千人のプラセボグループから185人感染。15千人の治験グループからは11人しか感染しなかったので94.1％有効って言ってるのか。恐ろしいほど原始的な調査なんだな。。— Angama (@Angama_Market) November 30, 2020
Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine https://t.co/9O1si9EPaV
Great news on Moderna vaccine— Anand Swaminathan (@EMSwami) November 30, 2020
196 infections: only 11 in vaccine arm
30 severe cases: all in placebo arm
Study's done. Applying for emergency use.
Now, let's see the data. Expert review neededhttps://t.co/fFCxfGkr8I
Let’s go. We are ready for some good news. Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine https://t.co/AF2vZ0hN0P— Judith Martin, MD (@martjm) December 1, 2020
More encouraging COVID-19 vaccine news.https://t.co/VKrGTCGaBE— Steve Daines (@SteveDaines) November 30, 2020
More good news on a potential #CovidVaccine as Moderna applies for emergency @US_FDA authorization.— Rep. Frank Pallone (@FrankPallone) November 30, 2020
We need a national rollout plan in place ASAP to ensure equitable distribution. The House-passed #HeroesAct requires one. It’s time for the Senate to act. https://t.co/65V33XTdJo
BREAKING: Moderna says its application seeking emergency use authorization for its Covid-19 vaccine has been submitted to the FDAhttps://t.co/0IeIxNv3Bd— CNBC Now (@CNBCnow) November 30, 2020
Modernaが、新データによって有効性が94%以上で安全だと確認できたとし、FDAに緊急利用の申請を行うと発表。https://t.co/CuNN7bUIfe— 今村咲 (@saki_imamura) November 30, 2020
Login to comment